Main header image

The application program will be available again in spring 2021. Please return then to view the updated Eligibility and Awards for the 2021 academic year! If you are an applicant who would like to discover more scholarship opportunities you might qualify for, please continue to the Scholarship America Hub and sign up!


Takeda Education Advantage University Scholarship Program
Application status: Closed

The Education Advantage program represents Takeda Pharmaceutical Company Limited’s ongoing commitment to the bleeding disorders community.

This program is administered by Scholarship America┬«, the nation’s largest designer and manager of scholarship, tuition assistance and other education support programs for corporations, foundations, associations, and individuals. Scholarship America is solely responsible for reviewing all scholarship applications, determining eligibility, and selecting recipients. Takeda Pharmaceutical Company Limited is not involved in the decision making process.

Applicants to the Education Advantage University Scholarship Program must meet all of the following criteria:

  • Be diagnosed with hemophilia A or B, including those with inhibitors (Factor VII or IX deficiency), or von Willebrand Disease.
  • Be a citizen or legal and permanent resident of the United States.
  • Be a high school senior, a high school graduate of any age, GED certified or a current postsecondary undergraduate student.
  • Plan to enroll in full-time undergraduate study at an accredited four-year college or university in the United States for the entire upcoming academic year.
  • Have a current or most recent cumulative grade point average of no less than 2.0 on a 4.0 scale (or its equivalent).
  • Be a lawful citizen (must not have had a felony conviction).

Applicants may only apply for an award from one program per year.


If selected as a recipient, the student will receive a $5,000 award. Awards may be renewed for up to three additional years or until a bachelor’s degree is earned, whichever occurs first. Renewal is contingent upon satisfactory academic performance in a full-time course of study, proof of an annual visit to a comprehensive clinic and continuation of the program by Takeda Pharmaceutical Company Limited.

Renewal may be extended beyond three years in the event that a student requires an additional year of study to complete a full-time course load or in the event that health problems or other exceptional circumstances result in a longer than traditional length of study.

Awards are for undergraduate study only and may be used for tuition, fees, books and supplies only.

Selection of Recipients

Scholarship recipients are selected on the basis of the following:

  • Academic record
  • Demonstrated leadership and participation in school and community activities
  • Work experience
  • Personal statement
  • Verification of diagnosis
  • Two online recommendations (one academic, one community)

Financial need is not considered. Selection of recipients is made by Scholarship America. In no instance does any officer or employee of Takeda Pharmaceutical Company Limited play a part in the selection. All applicants agree to accept the decision as final.


Applicants will be notified in mid August. Not all applicants to the program will be selected as recipients. Students not selected as recipients may reapply to the program each year they meet eligibility requirements.

Payment of Scholarships

Scholarship America processes scholarship payments on behalf of Takeda Pharmaceutical Company Limited. Payments are made in equal installments in September and December.

As part of your application, you must upload the following:

  1. A current, complete transcript of grades or copy of GED certificate. Grade reports are not accepted. Transcripts must display student name, school name, grades and credit hours for each course and term in which each course was taken.
  2. Medical Verification Form completed by you and your physician.
  3. Application Information Acknowledgment and Consent Form

Also as part of your application, an online recommendation must be submitted on your behalf no later than July 21, 2020 3:00 pm.

Your application is not complete unless all required documents are submitted electronically.

Takeda Pharmaceutical Company Limited has partnered with Scholarship America. Selecting the button below will redirect you the Scholarship America Student Hub!